Postępy Dermatologii i Alergologii

Full text

3/2026 vol. 43
Original paper

Management of paediatric anaphylaxis: evaluation of clinical practice according to the 2024 Polish Paediatric Society guidelines

Jadwiga Biela-Mazur 1
,
Kamila Danecka-Baran 1
,
Marcelina Żola 1
,
Weronika Biela-Nowaczyk 2
,
Łukasz Błażowski 1

  1. Allergology and Pneumonology Department, National Institute of Tuberculosis and Lung Diseases, Rabka-Zdroj, Poland

  2. Department of Atomic Physics and Nanophysics, Jan Kochanowski University, Kielce, Poland

Adv Dermatol Allergol 2026; XLIII (3): 253–259

DOI: https://doi.org/10.5114/ada.2026.162701
Data publikacji online: 2026/07/19
Article file
PDIA Management.pdf
  1. Dribin TE, Muraro A, Alvaro-Lozano M, et al. Anaphylaxis definition, overview, and clinical support tool: 2024 consensus report – a GA2LEN project. J Allergy Clin Immunol 2025; 156: 406-17.
  2. Tarczoñ I, Jedynak-W¹sowicz U, Lis G, et al. Is the clinical manifestation of anaphylaxis in children influenced by the trigger of reaction? Adv Dermatol Allergol 2021; 38: 788-97.
  3. Chu DK, Cruickshank H, Brozek J. Risk of anaphylaxis risk in schools – a systematic review. J Allergy Clin Immunol 2018; 141 (Suppl): AB157.
  4. B³a¿owski £, Cichocka-Jarosz E, Plata-Nazar K, et al. Anafilaksja u dzieci. Rekomendacje Polskiego Towarzystwa Pediatrycznego 2024. Przegl Pediatr 2024; 53: 7-27.
  5. Blazowski L, Majak P, Kurzawa R, et al. A severity grading system of food-induced acute allergic reactions to avoid the delay of epinephrine administration. Ann Allergy Asthma Immunol 2021; 127: 462-70.
  6. Cardona V, Ansotegui I, Ebisawa M, et al. World Allergy Organization anaphylaxis guidance 2020. World Allergy Organ J 2020; 13: 100472.
  7. Worm M, Moneret-Vautrin A, Scherer K, et al. First European data from the network of severe allergic reactions (NORA). Allergy 2014; 69: 1397-404.
  8. Höfer V, Dölle-Bierke S, Sabouraud-Leclerc D, et al. A growing concern for cashew and an unexpected risk from almonds: data from the anaphylaxis registry. Allergy 2025; 80: 2837-48.
  9. Worm M, Dölle-Bierke S, Faust L, et al. Recent findings from the anaphylaxis registry: where are we, where do we want to go? Allergol Select 2025; 9: 21-7.
  10. Dölle-Bierke S, Höfer V, Francuzik W, et al. Food-induced anaphylaxis: data from the European Anaphylaxis Registry. J Allergy Clin Immunol Pract 2023; 11: 2069-79.
  11. Jahnz-Ró¿yk K., Raciborski F, K³ak A, et al. Raport: Anafilaksja problem zdrowotny i spo³eczny. Warszawa 2016.
  12. Jahnz-Rozyk K, Raciborski F, Œliwczyñski AM, et al. Anaphylaxis in Poland: the epidemiology and direct costs. Adv Dermatol Allergol 2017; 34: 573-9.
  13. Tarczoñ I, Cichocka-Jarosz E, Knapp A, et al. The 2020 update on anaphylaxis in paediatric population. Adv Dermatol Allergol 2022; 39: 13-9.
  14. Thomson H, Seith R, Craig S. Downstream consequences of diagnostic error in pediatric anaphylaxis. BMC Pediatr 2018; 18: 40.
  15. Russell WS, Farrar JR, Nowak R, et al. Evaluating the management of anaphylaxis in US emergency departments: guidelines vs. practice. World J Emerg Med 2013; 4: 98-106.
  16. Candela E, Biserni GB, Ghizzi C, et al. Triage grading and correct diagnosis are critical for the emergency treatment of anaphylaxis. Children (Basel) 2022; 9: 1794.
  17. Cheng A. Emergency treatment of anaphylaxis in infants and children. Paediatr Child Health 2011; 16: 35-40.
  18. Höfer V, Dölle-Bierke S, Francuzik W, et al. Fatal and near-fatal anaphylaxis: data from the European Anaphylaxis Registry and National Health Statistics. J Allergy Clin Immunol Pract 2024; 12: 96-105.
  19. Bouderbala Y, Clark E, Tanno LK, et al. Anaphylaxis severity grade, during oral food challenges, assessed by five different classifications. Pediatr Allergy Immunol 2025; 36: e70065.
  20. Liu X, Lee S, Lohse CM, et al. Biphasic reactions in emergency department anaphylaxis patients: a prospective cohort study. J Allergy Clin Immunol Pract 2020; 8: 1230-8.
  21. Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014; 69: 1026-45.
  22. Tarczoñ I, Jedynak-W¹sowicz U, Lis G, et al. Intervention in anaphylaxis: the experience of one paediatric centre based on NORA reports. Adv Dermatol Allergol 2021; 38: 235-43.
  23. Grabenhenrich LB, Dölle S, Ruëff F, et al. Epinephrine in severe allergic reactions: the European Anaphylaxis Register. J Allergy Clin Immunol Pract 2018; 6: 1898-906.
  24. Patel N, Chong KW, Yip AYG, et al. Use of multiple epinephrine doses in anaphylaxis: a systematic review and meta-analysis. J Allergy Clin Immunol 2021; 148: 1307-15.
  25. Emergency treatment of anaphylaxis, Guidelines for healthcare providers, Working Group of Resuscitation Council UK, May 2021.
  26. Pouessel G, Jean-Bart C, Deschildre A, et al. Food-induced anaphylaxis in infancy compared to preschool age: a retrospective analysis. Clin Exp Allergol 2020; 50: 74-81.
  27. De Filippo M, Votto M, Albini M, et al. Pediatric anaphylaxis: a 20-year retrospective analysis. J Clin Med 2022; 11: 5285.
  28. Pereira RL, Gomes F, Guimarães MB, et al. Assessment of knowledge on the use of adrenaline autoinjectors in a pediatric Portuguese population. Glob J Ped Neonat Care 2025; 5: 1-6.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications